换一批In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
第一作者：
Yogesh,Kumar
第一单位：
Department of Metabolic & Structural Biology, CSIR-Central Institute of Medicinal & Aromatic Plants, Lucknow 226015, India; Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. Electronic address: kumar.yogesh601@gmail.com.
作者：
医学主题词
抗病毒药(Antiviral Agents);冠状病毒感染(Coronavirus Infections);半胱氨酸内肽酶类(Cysteine Endopeptidases);复方合剂(Drug Combinations);药物重新定位(Drug Repositioning);人类(Humans);分子构象(Molecular Conformation);分子动力学模拟(Molecular Dynamics Simulation);疾病大流行(Pandemics);种系发生(Phylogeny);肺炎, 病毒性(Pneumonia, Viral);蛋白酶抑制药(Protease Inhibitors);吡啶类(Pyridines);吡喃酮类(Pyrones);利托纳韦(Ritonavir);磺胺类(Sulfonamides);病毒非结构蛋白质类(Viral Nonstructural Proteins)
DOI
10.1016/j.jiph.2020.06.016
PMID
32561274
发布时间
2021-01-10
- 浏览0
Journal of infection and public health
1210-1223页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
